Heptocellular Cancer
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tremelimumab With Chemoembolization or Ablation for Liver Cancer (NCT01853618) | National Cancer Institute (NCI) | 2013-05-02 |
Track Heptocellular Cancer automatically
Every clearance here is in the API, with alerts when new ones post.